阿托伐他汀联合苯磺酸氨氯地平治疗冠心病合并脑梗死的临床效果研究

Study Clinical Effect on Atorvastatin Combined Benzene Sulfonic Acid Amlodipine in Treatment of Coronary Heart Disease With Cerebral Infarction

目的研究分析联合应用阿托伐他汀和苯磺酸氨氯地平治疗冠心病合并脑梗死的临床效果。方法选择本院实施诊治的72例冠心病合并脑梗死患者,随机为研究组和对照组,各36例,两组患者均予以常规治疗,基于此研究组联合应用阿托伐他汀和苯磺酸氨氯地平治疗,比较分析两组患者治疗前后血脂情况、心肌酶水平、ESS评分以及治疗后效果。结果治疗后,研究组血脂水平、心肌酶水平改善情况和ESS评分优于对照组,且治疗总有效率也高于对照组,差异有统计学意义(P<0.05)。结论联合应用阿托伐他汀和苯磺酸氨氯地平治疗冠心病合并脑梗死,疗效显著。

Objective To study the analysis of the combined use of atorvastatin and benzene sulfonic acid amlodipine for treatment of coronary heart disease with cerebral infarction.Methods Our hospital implementation of diagnosis and treatment of 72 patients with coronary heart disease with cerebral infarction, as research group and the control group, each group had 36 cases, two groups of patients were give regular treatment, based on the research team combined use of atorvastatin and benzene sulfonic acid amlodipine treatment, compared two groups of patients before and after treatment the blood fat, myocardial enzyme levels, ESS score and effect after treatment.Results After treatment, blood lipid level and improve the level of myocardial enzyme in patients with the team and ESS score was better than control group, and total effective rate was signiifcantly higher than the control group, the data was significant difference （P〈0.05）.Conclusion Combined use of atorvastatin and benzene sulfonic acid amlodipine therapy of coronary heart disease with cerebral infarction, curative effect is distinct.